COLLEDAN, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 13.394
AS - Asia 12.492
EU - Europa 9.482
SA - Sud America 2.470
AF - Africa 217
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 25
Totale 38.109
Nazione #
US - Stati Uniti d'America 13.080
SG - Singapore 4.588
HK - Hong Kong 3.453
RU - Federazione Russa 2.588
BR - Brasile 1.995
CN - Cina 1.907
IE - Irlanda 1.655
VN - Vietnam 1.560
IT - Italia 1.502
DE - Germania 1.054
SE - Svezia 1.042
GB - Regno Unito 371
UA - Ucraina 294
FR - Francia 241
AR - Argentina 210
CA - Canada 207
IN - India 160
ID - Indonesia 145
FI - Finlandia 127
KR - Corea 114
BD - Bangladesh 111
ES - Italia 108
NL - Olanda 108
ZA - Sudafrica 89
AT - Austria 85
EC - Ecuador 83
IQ - Iraq 78
TR - Turchia 70
BE - Belgio 61
MX - Messico 54
CO - Colombia 51
CH - Svizzera 48
JP - Giappone 45
DK - Danimarca 42
SA - Arabia Saudita 40
PL - Polonia 39
VE - Venezuela 37
PY - Paraguay 31
UZ - Uzbekistan 30
EG - Egitto 29
PK - Pakistan 27
KE - Kenya 24
CL - Cile 23
EU - Europa 23
PE - Perù 23
CZ - Repubblica Ceca 22
PT - Portogallo 22
MA - Marocco 21
AU - Australia 19
NP - Nepal 16
AE - Emirati Arabi Uniti 15
AZ - Azerbaigian 14
MY - Malesia 14
RO - Romania 14
UY - Uruguay 14
IR - Iran 13
TN - Tunisia 13
DO - Repubblica Dominicana 12
JM - Giamaica 12
JO - Giordania 12
KZ - Kazakistan 12
DZ - Algeria 11
RS - Serbia 10
CR - Costa Rica 8
LT - Lituania 8
OM - Oman 8
TW - Taiwan 8
AL - Albania 7
BG - Bulgaria 7
PS - Palestinian Territory 7
ET - Etiopia 6
IL - Israele 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
PH - Filippine 6
XK - ???statistics.table.value.countryCode.XK??? 6
BH - Bahrain 5
GR - Grecia 5
KG - Kirghizistan 5
LB - Libano 5
MU - Mauritius 5
CI - Costa d'Avorio 4
KW - Kuwait 4
LV - Lettonia 4
PA - Panama 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
ZW - Zimbabwe 3
AM - Armenia 2
EE - Estonia 2
HN - Honduras 2
HU - Ungheria 2
KH - Cambogia 2
LU - Lussemburgo 2
LY - Libia 2
Totale 38.087
Città #
Hong Kong 3.443
Singapore 2.618
Dublin 1.613
Ann Arbor 1.253
Ashburn 1.008
Princeton 817
New York 695
Fairfield 659
Frankfurt am Main 601
Chandler 586
Woodbridge 527
Santa Clara 503
Ho Chi Minh City 480
Dallas 455
Houston 414
Lawrence 385
Hanoi 357
Wilmington 356
Altamura 338
Moscow 298
Seattle 260
Milan 255
Beijing 237
Hefei 229
Los Angeles 218
Cambridge 207
Jacksonville 187
Chicago 177
The Dalles 176
São Paulo 163
San Diego 141
Buffalo 131
Shanghai 121
Andover 117
Dearborn 111
Toronto 111
Seoul 101
Rome 96
Jakarta 95
Nuremberg 81
Rio de Janeiro 74
Munich 73
London 68
Haiphong 61
Nanjing 61
Guangzhou 60
Salt Lake City 60
Hangzhou 56
Helsinki 52
Da Nang 51
Belo Horizonte 44
Boardman 44
Brasília 41
Biên Hòa 39
Curitiba 39
Brussels 37
Boston 36
Johannesburg 35
Atlanta 34
Norwalk 34
Vienna 33
Brooklyn 31
Changsha 30
Lachine 30
Campinas 29
Porto Alegre 29
Quận Bình Thạnh 28
Tashkent 28
Council Bluffs 27
Hải Dương 27
Tokyo 27
Pune 26
Quito 26
Tampa 26
Guayaquil 25
Ha Long 25
Shenyang 25
Thái Nguyên 25
Turin 25
Baghdad 24
Columbus 24
Elk Grove Village 24
Lappeenranta 24
Stockholm 23
Tianjin 23
Ribeirão Preto 22
San Francisco 22
Zhengzhou 22
Bologna 21
Dhaka 21
Erbil 21
Esslingen am Neckar 21
Falls Church 21
Guarulhos 21
Kilburn 21
Turku 21
Warsaw 21
Florence 20
Fremont 20
Vũng Tàu 20
Totale 22.598
Nome #
A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation 635
Reply to: “Outcome of in situ split liver transplantation in Italy over the last 25 years: An alternative analysis and personal view” 452
Recipient hepatectomy technique may affect oncological outcomes of liver transplantation for hepatocellular carcinoma 431
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 393
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 341
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 333
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 311
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 296
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 275
Health related quality of life in chronic liver diseases 272
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 261
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 258
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 247
Delaying surgery for patients with a previous SARS-CoV-2 infection 247
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 241
Multicentre evaluation of case volume in minimally invasive hepatectomy 239
Reno-portal bypass for non tumorous portal vein thrombosis in adult liver transplantation 234
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 231
Health Related Quality of Life in the Major Liver Conditions 231
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis 229
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 226
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 216
The impact of the COVID-19 outbreak on liver transplantation programs in Northern Italy 212
COVID-19: role of resilience on the psychological impact of lockdown in liver transplant transitional candidates and recipients COVID-19: ruolo della resilienza sull’impatto psicologico del lockdown nei candidati e nei riceventi del trapianto di fegato (adolescenti-giovani adulti) 210
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 210
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 210
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 208
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 206
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 202
Balancing donor and recipient risk factors in liver transplantation: The value of D-MELD with particular reference to HCV recipients 200
Treatment of hepatocellular carcinoma: A cost analysis of yttrium-90 transarterial radioembolization versus sorafenib 200
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list 195
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 192
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 187
Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients 186
Combined double lung-liver transplantation for cystic fibrosis without cardio-pulmonary by-pass. 186
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: Results from a 7-year experience 183
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 179
Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient 178
Extended right split liver graft for primary transplantation in children and adults. 177
Early detection of the graft failure after pediatric liver transplantation: a Bergamo experience 177
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 176
Covid-19 and gender: lower rate but same mortality of severe disease in women-an observational study 176
Nuclear expression of s100a4 calcium binding protein increases cholangiocarcinoma invasiveness and metastasization 175
Post-operative heparin reduces early venous thrombotic complications after orthotopic paediatric liver transplantation 175
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients 174
Trapianto intestinale 174
Biliary complications in pediatric liver transplantation: findings of percutaneous transhepatic cholangiography in a large single-center cohort 170
Portal vein thrombosis and liver transplantation: management, matching, and outcomes: a retrospective multicenter cohort study 165
Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus 160
A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the Liver Match study 160
Is minimally invasive liver surgery a reasonable option in recurrent HCC? A snapshot from the I Go MILS registry 160
Technical and Clinical Outcomes of Laparoscopic–Laparotomic Hepatocellular Carcinoma Thermal Ablation with Microwave Technology: Case Series and Review of Literature 159
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 159
Selective use of ex-situ machine perfusion after normothermic regional perfusion in liver transplantation from donation after circulatory death 159
Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma 155
Full-right-full-left split liver transplantation: The retrospective analysis of an early multicenter experience including graft sharing 155
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 155
Very Early Introduction of Everolimus in De Novo Liver Transplantation: Results of a Multicenter, Prospective, Randomized Trial 155
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 155
Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. 154
Venous outflow obstruction in pediatric left lateral segment split liver transplantation 152
Physiological reno-portal bypass in liver transplantation with non-tumorous portal vein thrombosis 146
Arterioportal fistulas (Apfs) in pediatric patients: Single center experience with interventional radiological versus conservative management and clinical outcomes 145
The Role of Imaging in Portal Vein Thrombosis: From the Diagnosis to the Interventional Radiological Management 144
Current Endovascular Management of Arterial Complications After Pediatric Liver Transplantation in a Tertiary Center 143
Improving outcomes of in situ split liver transplantation in Italy over the last 25 years 142
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 141
Extended criteria liver donation after circulatory death with prolonged warm ischemia: a pilot experience of normothermic regional perfusion and no subsequent ex-situ machine perfusion 138
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool 137
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective study 137
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 136
Living Donor Lung Transplantation After Hematopoietic Stem Cell Transplantation From the Same Donor: A Risk Worth Taking 134
Successful Lung Transplantation From a Donor With Previous Severe COVID-19 Pneumonia 132
A matched pair analysis of multicenter longterm follow-up after split-liver transplantation with extended right grafts 132
Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma 131
R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation 131
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial 130
Exploring auxiliary liver transplantation in the era of transplant oncology - A proposal for a new liver splitting program (ALERT-50) 130
Liver transplants in children: The 8 years experience in Bergamo 129
Liver transplantation for hepatocellular carcinoma: Bergamo experience 128
A national mandatory-split liver policy: A report from the Italian experience 127
Improving Outcome of Selected Patients With Non-Resectable Hepatic Metastases From Colorectal Cancer With Liver Transplantation: A Prospective Parallel Trial (COLT trial) 124
Liver Perfusion in Multiorgan Harvesting for Transplantation 123
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 120
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 119
Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: Are these still extended criteria liver grafts? 119
The Activity of the Liver-Transplant Center of Milan, Italy 119
Location and allocation: inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe 119
Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic 117
Evidence for biliary epithelial to mesenchymal transition in human cholangiocarcinoma 117
Results of 24 orthotopic liver transplantation in Milan 115
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 114
D-MELD, a Powerful Instrument To Optimize Donor-2-Recipient Match. Differences between US and Italy 113
Liver transplantation in patients with B viral hepatitis and delta infection 112
Transitional care in pediatric liver transplantation: do we need to structure a personalized program? 111
B-Hepatitis and Liver-Transplantation 111
EVIDENCE FOR EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN CHOLANGIOCARCINOMA 111
Pediatric liver transplantation: Indications, risk factors, and results 110
HEPATITIS-C VIRUS-INFECTION AND LIVER-TRANSPLANTATION 107
Totale 18.514
Categoria #
all - tutte 197.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021933 0 0 0 0 0 135 167 138 144 127 94 128
2021/20223.535 67 81 172 585 183 192 63 206 90 969 155 772
2022/20234.576 815 1.320 379 209 212 860 54 183 248 84 148 64
2023/20244.548 76 98 164 160 682 1.142 894 139 549 66 78 500
2024/202511.943 647 1.854 488 490 1.059 272 500 338 1.693 1.843 923 1.836
2025/202610.540 2.585 1.831 1.771 2.120 1.973 260 0 0 0 0 0 0
Totale 39.551